ARCHIVES

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer

October 28, 2011

NCI Diet Guideline Outlined At Senate Hearing

November 22, 1985

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014

Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion

May 31, 2002

NIH Study Sections Use New Scoring Procedure

July 3, 1998

ASCO Places Ad To Urge Increase In Research Funding.

June 13, 2008